BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1584 related articles for article (PubMed ID: 24012661)

  • 1. Tumor and its microenvironment: a synergistic interplay.
    Catalano V; Turdo A; Di Franco S; Dieli F; Todaro M; Stassi G
    Semin Cancer Biol; 2013 Dec; 23(6 Pt B):522-32. PubMed ID: 24012661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epithelial-to-endothelial transition and cancer stem cells: two cornerstones of vasculogenic mimicry in malignant tumors.
    Sun B; Zhang D; Zhao N; Zhao X
    Oncotarget; 2017 May; 8(18):30502-30510. PubMed ID: 27034014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoxia-mediated metastasis.
    Chang J; Erler J
    Adv Exp Med Biol; 2014; 772():55-81. PubMed ID: 24272354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gap junction as an intercellular glue: Emerging roles in cancer EMT and metastasis.
    Mao XY; Li QQ; Gao YF; Zhou HH; Liu ZQ; Jin WL
    Cancer Lett; 2016 Oct; 381(1):133-7. PubMed ID: 27490999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EMT and oxidative stress: a bidirectional interplay affecting tumor malignancy.
    Giannoni E; Parri M; Chiarugi P
    Antioxid Redox Signal; 2012 Jun; 16(11):1248-63. PubMed ID: 21929373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyaluronan: A modulator of the tumor microenvironment.
    Chanmee T; Ontong P; Itano N
    Cancer Lett; 2016 May; 375(1):20-30. PubMed ID: 26921785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxia-Inducible Factors: Master Regulators of Cancer Progression.
    Schito L; Semenza GL
    Trends Cancer; 2016 Dec; 2(12):758-770. PubMed ID: 28741521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer-associated-fibroblasts and tumour cells: a diabolic liaison driving cancer progression.
    Cirri P; Chiarugi P
    Cancer Metastasis Rev; 2012 Jun; 31(1-2):195-208. PubMed ID: 22101652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated level of mitochondrial reactive oxygen species via fatty acid β-oxidation in cancer stem cells promotes cancer metastasis by inducing epithelial-mesenchymal transition.
    Wang C; Shao L; Pan C; Ye J; Ding Z; Wu J; Du Q; Ren Y; Zhu C
    Stem Cell Res Ther; 2019 Jun; 10(1):175. PubMed ID: 31196164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer Stem Cells, Their Microenvironment and Anoikis.
    Ayla S; Karahüseyinogluc S
    Crit Rev Oncog; 2019; 24(1):27-34. PubMed ID: 31679217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer stem cells, the epithelial to mesenchymal transition (EMT) and radioresistance: potential role of hypoxia.
    Marie-Egyptienne DT; Lohse I; Hill RP
    Cancer Lett; 2013 Nov; 341(1):63-72. PubMed ID: 23200673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer stem cell secretome in the tumor microenvironment: a key point for an effective personalized cancer treatment.
    López de Andrés J; Griñán-Lisón C; Jiménez G; Marchal JA
    J Hematol Oncol; 2020 Oct; 13(1):136. PubMed ID: 33059744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting signal transduction pathways of cancer stem cells for therapeutic opportunities of metastasis.
    Iqbal W; Alkarim S; AlHejin A; Mukhtar H; Saini KS
    Oncotarget; 2016 Nov; 7(46):76337-76353. PubMed ID: 27486983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The tumor microenvironment: An irreplaceable element of tumor budding and epithelial-mesenchymal transition-mediated cancer metastasis.
    Li H; Xu F; Li S; Zhong A; Meng X; Lai M
    Cell Adh Migr; 2016 Jul; 10(4):434-46. PubMed ID: 26743180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microenvironment and tumor cell plasticity: an easy way out.
    Taddei ML; Giannoni E; Comito G; Chiarugi P
    Cancer Lett; 2013 Nov; 341(1):80-96. PubMed ID: 23376253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whom to blame for metastasis, the epithelial-mesenchymal transition or the tumor microenvironment?
    Pietilä M; Ivaska J; Mani SA
    Cancer Lett; 2016 Sep; 380(1):359-68. PubMed ID: 26791236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Redox regulation in stem-like cancer cells by CD44 variant isoforms.
    Nagano O; Okazaki S; Saya H
    Oncogene; 2013 Oct; 32(44):5191-8. PubMed ID: 23334333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIF expression and the role of hypoxic microenvironments within primary tumours as protective sites driving cancer stem cell renewal and metastatic progression.
    Philip B; Ito K; Moreno-Sánchez R; Ralph SJ
    Carcinogenesis; 2013 Aug; 34(8):1699-707. PubMed ID: 23740838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Redox mechanisms switch on hypoxia-dependent epithelial-mesenchymal transition in cancer cells.
    Cannito S; Novo E; Compagnone A; Valfrè di Bonzo L; Busletta C; Zamara E; Paternostro C; Povero D; Bandino A; Bozzo F; Cravanzola C; Bravoco V; Colombatto S; Parola M
    Carcinogenesis; 2008 Dec; 29(12):2267-78. PubMed ID: 18791199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer-derived exosomes trigger endothelial to mesenchymal transition followed by the induction of cancer-associated fibroblasts.
    Yeon JH; Jeong HE; Seo H; Cho S; Kim K; Na D; Chung S; Park J; Choi N; Kang JY
    Acta Biomater; 2018 Aug; 76():146-153. PubMed ID: 30078422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 80.